Back to results
US 2014/0155338 A1Published application
Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure
AssigneeBoehringer Ingelheim Vetmedica GmbH
InventorsJuergen DAEMMGEN, Olaf JOENS, Rainer KLEEMANN
Life of this patent
Estimating the term…
Abstract
A phosphodiesterase type III (PDE III) inhibitor or Ca2+-sensitizing agent or a pharmaceutically acceptable derivative thereof is provided for the preparation of a medication for the reduction of the heart size of a patient suffering from heart failure.
Claims27
A method for reducing heart size in a patient suffering from heart failure comprising administering to a patient suffering from heart failure at least one medicament comprising a therapeutically effective amount of pimobendan or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.